Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cardiac Science Inc. DFIB (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Fuzzy who wrote (166)	12/4/2003 11:43:51 AM
From: Skywatcher	Respond to of 174

And it's STILL FALLING....this thing is really starting to piss me off...... losing patience with it....absolutely no momentum except down even with good news on a decent market day..... CC

To: Fuzzy who wrote (166)	12/8/2003 9:55:53 AM
From: Skywatcher	Respond to of 174

Finally the BIG NEWS hits at the low point of the stock in recent memory! Cardiac Science Granted U.S. Patent Covering A Fully-Automatic Defibrillator For Use By Public Monday December 8, 1:30 am ET Company to Launch New Fully-Automatic AED in First Quarter 2004 IRVINE, Calif., Dec. 8 /PRNewswire-FirstCall/ -- Cardiac Science, Inc. (Nasdaq: DFIB - News) announced today it was granted a U.S. patent that covers a publicly-available portable defibrillator capable of being used by a bystander to automatically deliver life-saving defibrillation shock(s) to a heart attack victim. The issuance of the patent preludes the first quarter 2004 launch of Cardiac Science's fully-automatic version of its Powerheart® AED G3. This new version AED only requires that someone properly attach the AED to a heart attack victim in distress. No additional action is required by the rescuer since the device will analyze the patient's condition to detect a life-threatening heart rhythm and, if appropriate, deliver the life-saving defibrillation shock(s) to restore the victim's heart to a normal rhythm. This patent, No. 6,658,290, titled "Public Access Defibrillator" brings the total number of issued patents to 73 that Cardiac Science owns relating to a wide variety of external defibrillation technologies for use in public access and the hospital bedside. CC

To: Fuzzy who wrote (166)	7/2/2004 1:47:41 PM
From: Skywatcher	Respond to of 174

Cardiac Science Shares Jump on FDA OK WHOOOOOOOHOOOOOOOOO Friday July 2, 10:27 am ET Cardiac Science Shares Jump 35 Percent on FDA Approval of Automated External Defibrillator IRVINE, Calif. (AP) -- Shares of Cardiac Science Inc. soared 35 percent to $3.33 in early-morning trading Friday after the medical device maker said the Food and Drug Administration cleared its automated external defibrillator for commercial sale. The company said its Powerheart G3 defibrillator, which received patent protection last December, is designed for use by consumers with no medical training both at home and in public places.